SpectronRx Receives U.S. Nuclear Regulatory Commission Materials License for New Facility
CDMO, Contract Development, Contract Manufacturing, Nuclear Medicine, Radiopharmaceutical
0 Comment
Leading Radiopharma CDMO Opens Second Location